e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Cigarette smoke and particulate matter: basic science and clinical aspects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Involvement ferroptosis in COPD pathogenesis
M. Yoshida (Tokyo, Japan)
Source:
International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects
Session:
Cigarette smoke and particulate matter: basic science and clinical aspects
Session type:
Poster Discussion
Number:
4451
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Yoshida (Tokyo, Japan). Involvement ferroptosis in COPD pathogenesis. 4451
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Role of necroptosis in the pathogenesis of COPD
Source: International Congress 2019 – Mechanisms underlying acute exacerbation of respiratory disease
Year: 2019
Involvement of RIPK3-regulated necroptosis in IPF pathogenesis.
Source: International Congress 2017 – Novel mechanisms and therapeutic targets in lung injury and repair
Year: 2017
PARK2-regulated mitophagy in COPD pathogenesis
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
PP108 – Role of TRIM-16-mediated lysophagy in COPD pathogenesis
Source: ERS Lung Science Conference 2021
Year: 2021
Role of chaperone-mediated autophagy in COPD pathogenesis.
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
Involvement of NCOA4-mediated ferritinophagy in cigarette smoke-induced ferroptosis in COPD pathogenesis
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
Involvement of ferroptosis in COPD pathogenesis
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
Nrf2-regulated chaperon-mediated autophagy is involved in apoptosis modulation in COPD pathogenesis.
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020
Virus-induced ²vicius circles² of COPD pathogenesis
Source: Eur Respir J 2004; 24: Suppl. 48, 409s
Year: 2004
Involvement of Parkin-mediated mitophagy in COPD-related sarcopenia pathogenesis
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020
Chaperone-mediated autophagy modulates epithelial cell apoptosis in COPD pathogenesis.
Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms
Year: 2019
Defective metabolic adaptation in the pathogenesis of COPD
Source: International Congress 2019 – Metabolic alterations as a driver of chronicity in lung disease
Year: 2019
Lysosomal dysfunction in COPD pathogenesis.
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
Role of the inflammasome in the pathophysiology of antisynthetase-associated interstitial lung disease.
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021
Extracellular nucleotides contribute to the pathogenesis of viral-induced exacerbations in COPD via P2X4/P2X7-receptor activation
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019
Mitochondrial iron in the susceptibility, pathogenesis and progression of COPD
Source: Virtual Congress 2020 – Reflections from the Lung Science 2020 conference
Year: 2020
Mitochondrial iron in the susceptibility, pathogenesis and progression of COPD
Source: ERS Lung Science Conference 2020
Year: 2020
Investigation of the citrullination pathway in the pathogenesis of fibrotic lung disorders
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012
NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD
Source: Eur Respir J 2016; 47: 254-263
Year: 2016
Macrophage dysfunction in the pathogenesis and treatment of asthma
Source: Eur Respir J, 50 (3) 1700196; 10.1183/13993003.00196-2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept